News > Sri Lanka puts Chinese Sinopharm on hold, to use India-manufactured vaccine

Sri Lanka puts Chinese Sinopharm on hold, to use India-manufactured vaccine

Sri Lanka has put Chinese Sinopharm's Covid-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said. 

According to Cabinet co-spokesman, Dr Ramesh Pathirana, the Chinese vaccine Sinopharm has not yet completed phase 3 clinical trials. Dr Ramesh Pathirana said that Sri Lanka will depend mostly on the AstraZeneca vaccine from the Serum Institute of India.